Novian Health

  • About Us
    • Overview
    • Management
    • Board Of Directors
    • Investors
  • Research & Products
    • Novilase® Breast Therapy
    • Clinical Trials & Registries
    • Publications
    • Intellectual Property
  • News
    • News & Press Releases
    • Media Coverage
    • Upcoming Events
  • Contact
    • Careers

Novian Health Presents at William Blair Private Conference

October 17, 2007 by Novian Health

NOVIAN Health Presents at William Blair Private Equity Conference

CHICAGO – October 17, 2007 – Henry R. Appelbaum “Chip”, President and Chief Executive

Officer and Director of NOVIAN Health, Inc., presented at the William Blair & Company’s 10th Annual

Private Equity Conference held in Chicago. Mr. Appelbaum highlighted the company’s

accomplishments and the anticipated commercialization of NOVIAN Health’s Breast ILT System.

The conference provides an opportunity for private companies to present their near-term capital needs to an

audience of the leading private equity and venture investors in the U.S. The conference also highlights

the perspective and insights of William Blair & Company’s Equity Research teams, as they lead

discussions, moderate panels, and present their industry outlook to the conference participants.

NOVIAN Health Inc., located in Chicago, is a small, privately held company with proprietary

technology for the treatment of tumors using Interstitial Laser Therapy (ILT). The company has

developed, tested, and patented a minimally-invasive procedure that uses ILT (controlled heating) for

the ablation of breast tumors as an alternative to the surgically invasive, traditional “lumpectomy.” ILT

offers significant advantages over surgical removal including minimal scarring, quicker recovery times,

and only requiring local anesthesia. NOVIAN Health recently received its first FDA 510k clearance for

Fibroadenomas (benign tumors) of the breast and expects to offer its technology at centers around the

country. Their plan is to launch several centers nationwide that will be associated with existing surgical

practices. Approval for malignant tumors will also be sought.

Related Posts

  • Novian Health Announces Agreement with Rose Medical Center in Denver
  • Novian Health Announces Agreement with Tower Radiology Center in Tampa Bay
  • Novian Health Awarded New Patent for Breast Cancer Treatment Technology (05 Dec 2013)
  • Novian Health Presents at the “2nd Annual Venture Connections: A Frost & Sullivan Executive Symposium
  • Novian Health Receives FDA Approval to Study Breast Cancer Therapy (14 July 2011)

Filed Under: Archives

Recent Posts

  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)

ARCHIVES

  • December 2022
  • September 2021
  • August 2021
  • July 2021
  • February 2021
  • September 2020
  • June 2020
  • September 2019
  • July 2019
  • June 2019
  • December 2015
  • December 2014
  • September 2014
  • May 2014
  • December 2013
  • April 2013
  • February 2013
  • April 2012
  • October 2011
  • September 2011
  • July 2011
  • November 2010
  • December 2009
  • November 2009
  • October 2009
  • May 2009
  • June 2008
  • March 2008
  • October 2007
  • June 2007

Categories

  • Archives
  • Press Release 2011
  • Press Release 2012
  • Press Release 2013
  • Press Release 2014
  • Press Release 2015
  • Press Release 2019
  • Press Release 2020
  • Press Release 2021
  • Press Release 2022

CONTACT US

Novian Health Inc.
(Headquarters)
Novian Health Inc.
(Manufacturing)
222 W Merchandise Mart Plaza
Suite 1230
Chicago, Illinois 60654
1205 E State Avenue
Tonganoxie, KS 66086
Office: 312-266-7200 Office: 312-266-7200
Fax: 312-266-7202 Fax: 312-266-7202
Email: info@novianhealth.com Email: info@novianhealth.com

    

LATEST NEWS

  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)

Copyright © 2023 Novian Health. All Rights Reserved. Powered by